Search for: "ALZA CORPORATION"
Results 1 - 20 of 28
Sorted by Relevance | Sort by Date
7 Sep, 2006 6:47 pm
... Circuit upheld a lower court ruling in favor of IMPAX in its defense of a lawsuit brought by Alza Corporation, a Johnson & Johnson (NYSE:JNJ) unit. The suit alleged patent ... (R) XL (Oxybutynin Chloride) tablets, 5, 10 and 15 mg. Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence. U.S. ... Kluwer Health. "We are pleased that yet another court has
seen through Alza's attempt to delay the availability to patients of a lower priced alternative to the branded drug ...
26 Nov, 2006 9:52 pm
... previously reported, on September 6th the Court of Appeals for the Federal Circuit affirmed the invalidity of Alza's patent on Ditropan XL.
Ordinarily, one would have expected the FDA ... two months. On August 29, 2005, shortly before the district court invalidated Alza's patent on
Ditropan XL, Ortho-McNeil filed a citizen petition asking ... citizen petition appears to have resulted in an extra two months of market exclusivity for Alza. Even worse for Mylan (and Impax too, presumably) is that FDA's delay ...
27 Mar, 2008 8:21 am
... Personas Jurídicas, surge que los estatutos de la sociedad constituida en el extranjero, Ampex Corporation S.A., obrantes a fs. 1/19,
fueron inscriptos por ante el Juzgado Nacional ... ándole a dicha decisión carácter general. Contra dicha providencia se alza la sociedad,
interponiendo recurso judicial a fs. 651/58, por lo que la cuestión ... que se dio el carácter de Res. Gral. 5, impuso a la sociedad "Ampex Corporation" la obligación de llevar contabilidad por separado en la República. Se apela y se ...
4 Mar 7:08 am
... date in December 2009. Johnson & Johnson (J&J) acquired ALZA in 2001 for $10.5 billion. Another J&J subsidiary, Janssen ...
defects seem to be lesser evils when compared to the possibilities of a Chronogesic pump mishap. In 2000, ALZA Corporation knew that its intellectual property rights were coming to an end, and Duragesic ... amp;D, and wrote off the deferred royalties and commercial
rights that ALZA had received. The complexity of the pharmaceutical industry is one big, woven, tangled web ...
4 May, 2008 2:46 am
IP litigation can be facilitated by good organisation and forward planning. Ratiopharm (UK) Ltd v Alza Corporation; Alza Corporation v Sandoz Ltd, decided last week, is a case
in point, this being a Patents Court ... but didn't actually initiate proceedings against Sandoz until January of this year. In that action, Sandoz counterclaimed for revocation. In
this application Alza applied for an order that all the matters in dispute between itself, Ratiopharm and Sandoz be heard together. Ratiopharm
was ...
25 May, 2007 11:36 am
... Note: Is the CAFC apparently unconcerned about the effects of KSR because the CAFC had already adjusted their framework for obviousness analyses in anticipation of the ruling (See,
e.g., Dystar Textilfarben GMBH & Co Deutschland KG v. C.H. Patrick, Co., et al., Alza Corporation
v. Mylan Laboratories, Inc., et al., and Ormco Corporation, et al. v. Align Technology, Inc. etc)?
15 Jun, 2007 8:11 am
... before KSR v. Teleflex, it is worth noting that the CAFC applied an apparently adjusted framework for obviousness analyses in anticipation of the KSR ruling (See, e.g., Dystar
Textilfarben GMBH & Co Deutschland KG v. C.H. Patrick, Co., et al., Alza Corporation v. Mylan
Laboratories, Inc., et al., and Ormco Corporation, et al. v. Align Technology, Inc. etc).
2 Aug, 2006 1:49 pm
Johnson & Johnson's Alza drug unit sued Wyeth (Alza Corporation v. Wyeth, Wyeth Pharmaceuticals, Inc. Case No. 9:06-cv-00156-RHC ... depressive disorder, generalized anxiety disorder, social anxiety disorder
and panic disorder. Alza owns a patent 6,440,457, issued August 27, 2002, for a controlled release ... In the lawsuit was filed July 26 in
federal disctrict court in the Eastern District of Texas, Alza says the Wyeth drug is administered in that patented method. Wyeth says the '457
patent doesn' ...
7 Sep, 2006 3:46 pm
... brief (at pp. 3-7) to defend its obviousness standard now under attack at the Court in KSR ," the Federal Circuit in Alza Corporation v. Mylan Laboratories, Inc., et al. (September 6, 2006), began by reviewing the court's ... say there were some unknowns, but again lipophilic
drugs would be well absorbed. That would be-that was the general understanding at the time." Although Alza argues that two prior art references
"decisively undercut Dr. Amidon's hindsight opinion," these references are in fact ...
18 Jun, 2007 4:26 pm
... a Florida jury. Executives at Johnson & Johnson's Janssen Pharmaceutica Products and Alza Corp. subsidiaries knew some of the patches
were defective and continued to sell them anyway ... before a jury since a 2006 Houston state court jury said that Janssen and Alza must pay
$772,500 to the family of a Texas woman who died after her patch ... this year. The case is Lee Hendelson v. Janssen Pharmaceutica Products LLP and Alza Corporation, CA No. 05-8116, U.S. District Court for the Southern District ...
20 Feb 5:00 am
... to establish inventive step: ratiopharm (UK) Limited and another v Alza Corporation;
Alza Corporation and another v Sandoz Limited (PatLit) UK court holds ... Wireless and T-Mobile in
prepaid phone patent spat (Law360) Humanscale Corporation - Humanscale files new 337 complaint regarding ergonomic keyboard arms against ...
mark ownership in absence of trade mark licence between contracting parties: Laboratory Corporation of America v. Schumann (Property,
intangible) TTAB affirms 2(a) refusal, finding A ...
30 Oct, 2008 11:04 pm
... of Cicero, Illinois. The 38-year-old woman died in 2004 while wearing a Duragesic Pain Patch, manufactured by Alza Corporation and distributed by Janssen Pharmaceutica Products. Lead attorney for the family and Partner of HORP&B, Jim ... , died in February 2004 from
toxic effects of the drug fentanyl, the active ingredient in the Duragesic trans-dermal patch made by Alza Corp. and distributed by Janssen
Pharmaceutica Products, according to a complaint filed by her husband, John. "Each patch has ...
21 Nov, 2008 10:41 pm
... pain she experienced from a neurological condition called "reflex sympathetic dystrophy." The patch was part of a lot of patches that ALZA
recalled in 2004 due to seal breaches that allowed leakage that could cause an increased, life-threatening absorption of the ... , were the lead attorneys representing the DiCosolo
family in the case against the defendants, Janssen Pharmaceutica Inc. and ALZA Corporation. Orr and
Heygood were assisted in the case by HORP&B Partner Charles Miller. According to ...
2 May, 2007 11:33 am
... the KSR Court when it issued three post-certiorari decisions related to obviousness (In re Kahn, Dystar and Alza Corp.) . Justice Kennedy
acknowledged these decisions in the opinion and said: "We note the Court of Appeals has ... when evaluating obviousness. The KSR decision mentions the phrase 5 times in the opinion.
Dystar mentions it 10 times. --------------------- DOWNLOAD: Dystar Textilfarben GMBH v. C.H. Patrick, Co. (link) Alza Corporation v. Mylan Laboratories, Inc. (link) In re Kahn (link)
3 Dec, 2008 1:58 pm
... DiCosolo's family argued that the defendants, Titusville, N.J.-based Janssen Pharmaceutica Inc. and Mountain View, Calif.-based ALZA
Corporation, knew about the Duragesic patch's problems, which allowed the patches to leak fentanyl in amounts large enough to kill the patients
using it. Both Janssen and ALZA are subsidiaries of Johnson & Johnson. "They knew this patch was dangerous and defective but they continued
to sell it and make money, ...
6 Jun, 2007 8:36 am
Just yesterday we put the jury in the box in our case against ALZA Corporation and Janssen
Pharmaceutica. Opening statements went well. My partner, Jim Orr, put on our first witness, Dr. Scheuler, Chief Toxicologist of the Broward County Medical...
12 Jun, 2008 9:53 am
... "The requirements imposed by AICRA's verbal threshold do not apply to negligent-infliction-of-emotional-distress claims fashioned on the liability theory set out in Portee v.
Jaffee." Smith et al v. ALZA Corporation et al "An entity whose activities are limited exclusively to
product packaging and labeling comes within the definition of "manufacture," to whom strict liability for product defect may attach, and is not a "product ...
22 Nov, 2008 5:14 am
... death. The very day that DiCosolo's husband reported his wife's death, a recall of the defective patches was announced. The patch DiCosolo was wearing at the time of her death came
from the recalled batch. Jurors reportedly found that the manufacturers of the patch, Janssen Pharmaceutical, Inc and ALZA Corporation were aware of the problems with the patch. the defendants have vowed to appeal the award.
4 Dec, 2008 4:19 am
... suffering from chronic neck pain died as a result of using the "Duragesic" Fentanyl skin patch. The jury awarded the estate of the victim $16.6 million. Alza Corporation, the patch makers, and Janseen Pharmaceutica, the distributors, are the Johnson & Johnson units
named in the suit. Fentanyl, a narcotic, is 100 times stronger than morphine. Patches have been recalled after defects and overdose deaths were reported. This trial is ...
25 Nov, 2008 6:19 pm
... morphine. DiCosolo's family filed a wrongful death lawsuit against Titusville, N.J.-based Janssen Pharmaceutica Inc. and Mountain View, Calif.-based ALZA Corporation. The family alleged that the companies knew the patches leaked fentanyl in large enough doses to
kill patients. The patch DiCosolo was using was part of a larger group of defective patches that were recalled in 2004 by the Food and Drug Administration. The ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!